Ip Share Discussion Threads

[riddlerone] 13/10/2020 14:11

Stig,been on here while he was in his nappies.Take your beef back to Lse please

[p1nkfish] 13/10/2020 13:23

They were in Ox Nano up to their balls so no problem letting the % ebb so long as value goes up.

They have probably developed a list of "next" areas and could be in Quantum Comp, Fusion and Digital (boring).

[rogerrail] 13/10/2020 12:22

Makes you wonder what IPO plan to do with all the cash they are accumulating, perhaps they want to sell out on this as well?

[wetpantz] 13/10/2020 11:17

Frustrating that IPO not participating in ONT fundraisings and allowing the stake to be diluted. Now down to 15%. Unless of course there is a plan to acquire a sizeable tranche from Invesco/Lansdowne

[riddlerone] 13/10/2020 07:44

That ok bamboo2 yours looks better.Nice contract value and interesting website,may use it for future reference.

[bamboo2] 13/10/2020 07:36

riddler, Sorry I didn't see you had already posted!

[bamboo2] 13/10/2020 07:32

A very decent sized order for ONT

[bamboo2] 13/10/2020 07:31

IP Group PLC

13 October 2020


FOR RELEASE ON 13 October 2020

IP Group plc - Portfolio company Oxford Nanopore Technologies announces GBP84.4m of additional funding

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Ltd ("Oxford Nanopore" or "the Company") has announced that it has raised an additional GBP84.4 million of new capital from existing and new investors including International Holdings Company (IHC) and RPMI Railpen.

The funds will be used to support the rapid acceleration of Oxford Nanopore's commercial and manufacturing operations as well as ongoing innovation in the field of nanopore technology. The round takes the amount raised this year by Oxford Nanopore to GBP162.1 million, following fund raisings in January and May of GBP29.3 million and GBP48.4 million respectively.

Following the capital raise, IP Group has a 15.0% undiluted beneficial stake in Oxford Nanopore, valued at GBP257.7 million. The directors will review the carrying value of Oxford Nanopore, as usual, as part of the Group's Annual Results for 2020 in light of this funding round and all other relevant information.

Last week, Oxford Nanopore announced that its LamPORE test is now CE marked for in vitro diagnostic use for the detection of the SARS-CoV-2 virus that causes COVID-19, using its GridION device. Its LamPORE test is now in the process of initial rollouts in the UK, Germany, Switzerland and the United Arab Emirates.

The Company previously announced that it had partnered with the UK's Department of Health and Social Care with an initial order of 450,000 LamPORE SARS-CoV-2 tests and the potential to increase to millions of tests per month as indicated by the recent publication of a contract award notice of GBP112.6m on the TED (Tenders Electronic Daily) website. Further regulatory approvals are being pursued in other countries, including Emergency Use Authorisation in the United States, and with its partner G42 in the United Arab Emirates.

[benchmark] 12/10/2020 09:14

Bamboo2 - "because the announcement was made mid morning, some will have missed it completely. Others will miss the significance, as IPO is a holding company. It also could be that the market views this news as already 'in the price'."

No move in share price this morning effectively rules out the first 2 above. Also, with regard to it being already in the sp, when did the share price reflect this? I don't believe it did at all.
There remains another alternative, i.e. persistent selling into any perceived rise.

I agree with you about the prospects for ONT. But in my view there are far more "next significant events" to happen before the development of testing using mobile telephony.

[empoggio] 10/10/2020 15:01

DVRG are steps ahead on your last comment: 'personal testing using a mobile phone'.

[bamboo2] 10/10/2020 12:28

Benchmark, because the announcement was made mid morning, some will have missed it completely. Others will miss the significance, as IPO is a holding company. It also could be that the market views this news as already 'in the price'.

Undoubtedly, the news will result in a huge increase in the size of the market for ONT. As a result of this ONT kit will one way or another find its way into every single clinical pathology lab in the world.

The next significant events for ONT will involve a broadening of the diagnosis side, and the advent of personal testing using a mobile phone.

I am quite excited by the potential for ONT.

[p1nkfish] 10/10/2020 12:09

Thanks bamboo. Useful background info on invesco etc.

[benchmark] 10/10/2020 10:43

Bamboo - thank you for taking the time to reply with that helpful information.

With the announcement that ONT obtained the CE mark for the GridIon & MinIon systems, one would have thought/hoped that it would have been reflected in the IPO share price yesterday afternoon. The fact that it wasn't suggests measured selling into any perceived rise?

[bamboo2] 10/10/2020 09:36

Benchmark, for all their faults, Invesco have been good at fulfilling the obligation to file an rns when they have crossed notifiable limits.

The total holding is currently 13.49%, and this is unchanged. Any transactions are normally signalled the following day, so in theory we could get an RNS on Monday.

The redemption problems at Invesco exist with the UK Equity High Income Fund. This holds a number of quoted and unquoted companies, whose valuations continue to be adversely affected by the Woodford firesale, and other factors.

One of the unquoted's they have is ONT. There are at least three interested potential buyers for ONT [Tencent and others] with cash, but afaik no deal has yet been done. I guess that Invesco would want to package up any deal involving ONT, with a load of less desirable stock.

Other than the top ten holdings in Invesco's fund, which are published monthly, we have to wait for an end of year report to find out how the holdings have changed.

[benchmark] 10/10/2020 08:27

Does anyone know how much of Invesco's 13.5% stake has been sold into the market at this stage? Obviously, it is still above 5%, otherwise we would have had an RNS

[bamboo2] 09/10/2020 09:06

Latest ONT vid on twitter suggesting that production is ramping up in expectation of increase in orders for Lampore CV19 test

[rogerrail] 07/10/2020 11:29

Just wondering what it will take to get this to breakout from its 80p ceiling. Clearly big seller (Invesco?) happy to take that for its shares all day long.I am not a fan of share buybacks but this is one situation where it is warranted.

[bamboo2] 07/10/2020 08:15

Hi p1nk, yes. They keep the co. although it will have reduced value.

If future products are a success, then there will be extra payments.

We are still awaiting the ONT CE mark!
Now would be a good time to get their skates on.

[p1nkfish] 07/10/2020 08:13

With that much cash they won't be looking to fund small fry as they would never manage the portfolio. It's probably ideas looking for 10M+ & real game changers/moonshots.

A re-orientation of the portfolio is possible.

What do they know that the martket is unaware of that warrants such a cash pile now?

[p1nkfish] 07/10/2020 08:06

They have some decent fire power ready to allocate.
Where & when?

[p1nkfish] 07/10/2020 08:05

They keep their holding bamboo, the upside is just for the product sale, not sale of the company?